To include your compound in the COVID-19 Resource Center, submit it here.

Adaptive, Microsoft to develop universal TCR-antigen map

Adaptive Biotechnologies Corp. (Seattle, Wash.) and Microsoft Corp.(NASDAQ:MSFT) partnered to develop a universal map of T cell receptors (TCRs) and their

Read the full 217 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE